Rob Ford remains on call despite undergoing first phase of chemotherapy today

Written by admin on 14/11/2018 Categories: 老域名出售

TORONTO —; Former Toronto mayor Rob Ford will undergo his first round of chemotherapy in Toronto today after he announced last week that doctors have discovered a tumour on his bladder.


“Councillor Ford has been at the hospital several times this week, undergoing additional tests and consulting with his health team,” said Ford’s Chief of Staff Dan Jacobs in a statement, adding that he is undergoing chemotherapy at Mount Sinai Hospital.

“The working diagnosis is that it is cancerous, and doctors were unable to confirm if it is a single tumour, or if it is smaller tumours close together.”

READ MORE: Rob Ford announces doctors have discovered new tumour on his bladder

Doctors believe the tumour was similar to the pleomorphic liposarcoma he was diagnosed with in Sept. 2014 that was surgically removed in May.

“At this time, we still do not have definitive test results indicating if there is any organ involvement, or the size of the tumours,” the statement read, adding that Ford is remaining on call despite his health.

“Councillor Ford wishes to assure the people of Toronto that he will continue to provide assistance however possible, and to contact his office at (416) 397-9255 with any issues they are encountering, or call him at home at (416) 233-6934.”

READ MORE: Tory wishes Rob Ford ‘speedy recovery’ from health setback

Ford said he began feeling a sharp, shooting pain about a month ago after urinating.

The councillor mentioned last week he was debating whether to seek treatment at medical facilities in the U.S., either in Texas or New York, but didn’t “want to offend the people that saved my life a year ago.”

Ford’s health caused him to drop out of the 2014 mayoral race. His brother Doug ran in his place, but lost to John Tory.

Ford has been sitting as a councillor for Etobicoke Ward 2 since Oct. 2014.


Comments Off on Rob Ford remains on call despite undergoing first phase of chemotherapy today